Palliative Treatment of Bone Metastases in Hormone-Refractory Prostate Cancer: Effects of Pamidronate on the Carboxyterminal Telopeptide of Type-I Collagen Level in Patients with Increasing Prostate-Specific Antigen Levels

Publisher： Karger

E-ISSN： 1423-0399|78|4|345-350

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.78, Iss.4, 2007-05, pp. : 345-350

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prostate-Specific Antigen Levels and Prognosis in Patients with Hormone-Refractory Prostate Cancer Treated with Low-Dose Dexamethasone

By  

Urologia Internationalis, Vol. 68, Iss. 1, 2002-01 ,pp. : 10-15

Karger

Access to resources Recommend Favorite

Prospective Evaluation of Samarium-153-EDTMP Radionuclide Treatment for Bone Metastases in Patients with Hormone-Refractory Prostate Cancer

By  

Urologia Internationalis, Vol. 78, Iss. 1, 2007-01 ,pp. : 50-57

Karger

Access to resources Recommend Favorite

TREATMENT WITH PREDNISOLONE OF HORMONE-REFRACTORY PROSTATE CANCER

By Fuse H.   Nozaki T.   Fujiuchi Y.   Mizuno I.   Nagakawa O.   Okumura A.  

Archives of Andrology, Vol. 52, Iss. 1, 2006-01 ,pp. : 35-38

Informa Healthcare

Access to resources Recommend Favorite

The relationship between prostate‐specific antigen and TNM classification or Gleason score in prostate cancer patients with low prostate‐specific antigen levels

By  

THE PROSTATE, Vol. 75, Iss. 10, 2015-07 ,pp. : 1034-1042

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rising Prostate-Specific Antigen after Primary Treatment of Prostate Cancer: Sequential Hormone Manipulation

By  

Urologia Internationalis, Vol. 79, Iss. 2, 2007-09 ,pp. : 95-104

Karger

Access to resources Recommend Favorite